OptimizeRx (NASDAQ:OPRX) Price Target Lowered to $8.00 at JMP Securities

OptimizeRx (NASDAQ:OPRX – Free Report) had its target price decreased by JMP Securities from $16.00 to $8.00 in a research report report published on Thursday morning,Benzinga reports. JMP Securities currently has a market outperform rating on the stock. Other analysts have also recently issued research reports about the stock. Barclays dropped their target price on […]

Leave a Reply

Your email address will not be published.

Previous post Cisco Systems (NASDAQ:CSCO) Given New $62.00 Price Target at UBS Group
Next post Buhler Industries (TSE:BUI) Hits New 1-Year High – Time to Buy?